|Articles|December 8, 2022
- Pharmaceutical Executive-12-01-2022
- Volume 42
- Issue 12
Pharmaceutical Executive, December 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
2023 Pipeline Report: Testing the Limitsabout 3 years ago
Business and Passionabout 3 years ago
Back in Person, Sparks Could Fly at Upcoming J.P. Morgan Conferenceabout 3 years ago
Aligning Trust and Transparency in Brand Messagingabout 3 years ago
Pharma Needs to Look Internally for New Leadershipabout 3 years ago
Seeking Concrete Solutions to Europe’s Supply Problemsabout 3 years ago
Pandemic and Politics Shaped Pharma and FDA in 2022about 3 years ago
Medical Affairs Uptickover 3 years ago
Virtual Medical Affairs Audits: A Viable AlternativeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

